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Background: Pseudomonas aeruginosa is an important cause of morbidity and mortality in
patients with burns.
Method: A total of 214 nonduplicated burn wound isolates of P. aeruginosa were recovered
from burn patients. Identification of carbapenem resistant isolates and their antimicrobial
susceptibility pattern was carried out using the phenotypic methods. The presence of genes
encoding extended spectrum beta-lactamases (ESBLs) and metallo-beta-lactamases (MBLs)
enzymes were determined by PCR. The genetic relationships between carbapenem resistant
isolates were determined by Random Amplified Polymorphic DNA (RAPD)-PCR.
Results: Of 214 investigated P. aeruginosa isolates, 100 (46.7%) were carbapenem resistant. All
carbapenem resistant P. aeruginosa were resistant to imipenem, meropenem, ertapenem,
carbenicillin, aztreonam, gentamicin and ciprofloxacin but susceptible to polymyxin B.
Among 100 carbapenem resistant P. aeruginosa isolates, 3%, 65% and 52% were identified as
ESBLs, carbapenemase and AmpC overproduction positive isolates respectively. The most
prevalent ESBLs and MBLs genes included blaOXA-10 (97%), blaTEM (61%), blaVIM (55%), blaPER
(13%), blaIMP (3%) and blaAIM (1%). RAPD analysis yielded 13 distinct profiles among 92
isolates. A dominant RAPD type was designated as A that consisting of 80 isolates.
Conclusion: This is the first report of Adelaide IMipenmase (AIM) MBLs producing P. aeru-
ginosa from Iran and also of the high prevalence of AmpC overproduction isolates. According
to the results of current study, P. aeruginosa isolates producing OXA-10, TEM, VIM, PER and
IMP beta-lactamases are frequent and the population structures of these isolates are highly
similar.
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Patients with thermal injuries are usually at a high risk of
nosocomial infection. Pseudomonas aeruginosa is known as an
important cause of morbidity and mortality in patients with
burns [1].
Carbapenems are the most important therapeutic options
that effect against serious infections caused by P. aeruginosa
strains producing extended spectrum beta-lactamases (ESBLs)
and chromosomal cephalosporinases (AmpC-beta-lacta-
mases) [2]. However, the emergence of carbapenem resistance
among P. aeruginosa is an increasing problem in many parts of
the world [3,4]. Resistance against carbapenem by P. aeruginosa
may be occurred through different mechanisms including:
loss of the outer membrane porin OprD protein, reduced levels
of drug accumulation due to efflux-pumps over-expression
and increased production of AmpC beta-lactamases. Also, P.
aeruginosa may obtain genes encoding carbapenemase
enzymes such as metallo-beta-lactamases (MBLs) or Klebsiella
pneumoniae carbapenemase (KPC) [2,5,6]. The MBL enzymes are
able to hydrolyze carbapenems efficiently and thus they are
considered the most clinically significant mechanism of
carbapenem resistance in P. aeruginosa isolates [6–9].
Multi-drug resistant P. aeruginosa has emerged as an
important pathogen in Iran compared to other countries,
which confronted clinicians with serious challenges for
treating infected patients. There are several reports on the
prevalence of blaVIM and blaIMP among carbapenem resistant P.
aeruginosa strains isolates from burn patients in Iran but the
characteristics of other mechanisms of resistance to carba-
penems such as AmpC producer (AmpC overproducer) and
KPC are unknown [4,10,11]. This study was designed to
determine the existence of different genes encoding beta-
lactamase among carbapenem resistant P. aeruginosa isolated
from burn patients in Tehran, Iran in a period of two years.
2. Materials and methods
2.1. Bacterial strains
A collection of 214 isolates of P. aeruginosa were recovered from
burn patients who were admitted to Shahid Motahari Hospital
of Tehran University of Medical Sciences during 2011 and 2012.
All the strains were isolated from burn wounds and only one
isolate per patient (according to patient’s names and ID) was
included in the study. Bacterial identification was performed
by standard biochemical tests [12]. Briefly was based on colony
morphology, Gram staining, ability to produce oxidase and
catalase, no acid production in the slant or butt of Kligler iron
agar, oxidative-fermentative (OF) test, pigment production
and growth in 42 8C. Isolates identified as carbapenem
resistant P. aeruginosa were investigated in accordance to
the aims of study.
2.2. Antimicrobial susceptibility testing
Carbapenem resistant isolates and their antimicrobial sus-
ceptibility patterns were investigated using the disk diffusionPlease cite this article in press as: Neyestanaki DK, et al. Determination o
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10.1016/j.burns.2014.02.010method according to the Clinical and Laboratory Standard
Institute (CLSI) guidelines [13]. The following antibiotics
(MAST, UK) were tested: Imipenem (10 mg), meropenem
(10 mg), ertapenem (10 mg), polymyxin B (300 Unit), cefotaxime
(30 mg), ceftazidime (30 mg), cefepime (30 mg), cefoxitin (30 mg),
gentamicin (10 mg), ceftriaxone (30 mg), carbenicillin (30 mg),
aztreonam (30 mg) and ciprofloxacin (5 mg). ESBLs producing
strains were detected using the combined double-disk test
[4,13]. Organisms were also screened for carbapenemase
production by the modified Hodge test [13].
The minimum inhibitory concentrations (MICs) of imipe-
nem (IMI), meropenem (MEM) and ceftazidime (CAZ) were
determined by the microbroth dilution method. Susceptibility
breakpoints were defined according to CLSI recommenda-
tions. P. aeruginosa ATCC 27853, Escherichia coli ATCC 25922 and
K. pneumoniae 700603 were used as controls.
AmpC overproduction was confirmed according to the
method of Rodrı´guez-Martı´nez et al. [8]. The isolates were
considering as AmpC overproduction when there was at least
a twofold dilution difference between the MICs of CAZ, IMI and
MEM and the MICs of CAZ, IMI and MEM plus cloxacillin.
2.3. DNA extraction and PCR detection of b-lactamases
genes
The whole genomic DNA from cultured strains was prepared
using genomic DNA Extraction Kit (tip 100; Bioneer, Korea)
according to the manufacturer’s instructions. The blaTEM,
blaSHV, blaPER, blaPSE, blaCTX-M, blaOXA-10, blaOXA-48, blaKPC, blaGES,
blaVIM, blaIMP, blaGIM, blaAIM, blaSPM, blaNDM and blaSIM genes
were detected by PCR method using specific oligonucleotide
primers listed in Table 1. The PCR mixtures (25 ml) contained
3 ml of DNA, 12.5 ml of PCR master mix (Sinaclon, Iran), and
0.5 mM of each primer; Reaction conditions for all the primers
were as follows: initial denaturation at 95 8C for 5 min; 30
cycles of denaturation at 95 8C for 1 min, primer annealing at
47 8C to 61 8C (Table 1) for 1 min and extension at 72 8C for
1 min; followed by a final extension step of 72 8C for 5 min.
Amplicons were revealed by electrophoresis on a 1.2% agarose
gel and a subsequent exposure to UV light in the presence of
KBC power load dye (GelRed Nucleic Acid Gel Stain, 10,000 in
water, Kawsar Biotech Co., Tehran, Iran).
2.4. RAPD PCR amplification
The primer used for Random Amplified Polymorphic DNA
(RAPD) PCR were RAPD-208 (50-AGCGGGCCAA-30) and 272 (50-
ACGGCCGACC-30) [20,21]. The RAPD PCR amplification was
carried out in T-100 (BioRad) by using PCR Master Kit (Sinaclon
Inc., Tehran, Iran) according to manufacture guideline. PCR
conditions were as follows: initial denaturation at 95 8C for
5 min followed by 30 cycles of denaturation at 95 8C for 1 min,
annealing at 38.5 8C for 1 min, extension at 72 8C for 2 min. The
final extension step was continued for another 10 min at 72 8C.
PCR products were then separated by electrophoresis in 1.5%
agarose gels with 0.5 TBE buffer. DNA bands were observed
by staining with KBC power load dye and photographed under
UV illumination. RAPD patterns were analyzed visually and
any pattern differing by one or more bands was classified as a
distinct RAPD type.f extended spectrum beta-lactamases, metallo-beta-lactamases and
ginosa isolated from burn patients. Burns (2014), http://dx.doi.org/
Table 1 – Primers used for the amplification of different beta-lactamase genes among carbapenem-resistant Pseudomonas
aeruginosa isolates.
Gene target Primer sequence (5’-3’) Annealing temperature (8C) Product size (bp) Reference
blaSHV F - TCAGCGAAAAACACCTTG
R - TCCCGCAGATAAATCACC
51 472 [14]
blaTEM F - CTTCCTGTTTTTGCTCAC C
R - AGCAATAAACCAGCCAGC
54 636 [14]
blaOXA-10 F - TCAACAAATCGCCAGAGAAG
R - TCCCACACCAGAAAAACCAG
56 276 [15]
blaPER F - GGGACARTCSKATGAATGTCA
R - GGYSGCTTAGATAGTGCTGAT
47 926 [15]
blaPSE F - AATGGCAATCAGCGCTTC
R - GCGCGACTGTGATGTATA
48 698 [16]
blaVIM F - ATGTTAAAAGTTATTAGTAGT
R - CTACTCGGCGACTGAGCGAT
53 801 [17]
blaGES F - ATGCGCTTCATTCACGCAC
R - CTATTTGTCCGTGCTCAGG
56 844 [18]
blaAIM F - CTGAAGGTGTACGGAAACAC
R - GTTCGGCCACCTCGAATTG
59 322 [19]
blaOXA-48 F - GCGTGGTTAAGGATGAACAC
R - CATCAAGTTCAACCCAACCG
58 438
blaNDM F - GGTTTGGCGATCTGGTTTTC
R - CGGAATGGCTCATCACGATC
58 621
blaSIM F - TACAAGGGATTCGGCATCG
R - TAATGGCCTGTTCCCATGTG
61 570
blaGIM F - TCGACACACCTTGGTCTGAA
R - AACTTCCAACTTTGCCATGC
58.5 477
blaSPM F - AAAATCTGGGTACGCAAACG
R - ACATTATCCGCTGGAACAGG
59 271
blaIMP F - GGAATAGAGTGGCTTAAYTCTC
R - GGTTTAAYAAAACAACCACC
58 232
blaKPC F - CGTCTAGTTCTGCTGTCTTG
R - CTTGTCATCCTTGTTAGGCG
58 798 and 232
blaCTX-M F - GCGATGGGCAGTACCAGTAA
R - TTACCCAGCGTCAGATTCCG
60 392 This study
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Amongst 214 detected P. aeruginosa isolates, 100 (46.7%)
identified as carbapenem resistant strains. All carbapenem
resistant P. aeruginosa were resistant to imipenem, merope-
nem, ertapenem, carbenicillin, aztreonam, gentamicin, and
ciprofloxacin. All isolates were susceptible to polymyxin B.
Fewer than 84% were resistant to ceftazidime, but more than
98% were resistant to cefepime. By the compound disk test, the
modified Hodge test and determination of MICs of beta-
lactams, among the 100 carbapenem resistant P. aeruginosa
isolates, 2 (2%) were ESBLs producing strains, 37 (37%) were
carbapenemase producers and 23 (23%) showed AmpC
overproduction respectively. One (1%) isolate was both ESBLs
and AmpC positive and 28 (28%) isolates were carbapenemase
and AmpC positive simultaneously.
The prevalence of resistance genes, RAPD types and MIC of
carbapenem resistant P. aeruginosa isolates have been sum-
marized in Table 2. Of the 16 studied bla genes, only 6 were
detected and 97% of the test strains carried the blaOXA-10 gene,
61% the blaTEM gene, 55% the blaVIM gene, 13% the blaPER gene,
3% the blaIMP gene and finally 1% of the test strains possessed
the blaAIM gene. Out of 100 carbapenem resistant P. aeruginosa
strains, 92 isolates were typed by RAPD typing method. RAPD
analysis yielded 13 distinct profiles among 92 investigated
isolates. Two clusters of isolates shared the same RAPDPlease cite this article in press as: Neyestanaki DK, et al. Determination o
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10.1016/j.burns.2014.02.010patterns, while 11 isolates had unique RAPD patterns. A
dominant RAPD type designated as A that consisting of 80
isolates.
4. Discussion
The high prevalence of carbapenem resistant P. aeruginosa,
which accounts for 38–66% of all P. aeruginosa isolates, causing
burn infections in Iranian hospitals, has greatly affected
infection control and medical treatment [4,10,11]. In this study
the rate of carbapenem resistance among P. aeruginosa isolates
was 46.7%, which was higher than similar report from Kuwait
(10.4%) but lower than what was reported from Saudi Arabia
(70%) [22,23]. However, carbapenem resistant P. aeruginosa rates
vary greatly among different area which may reflect differences
in infection control policies and other factors [8,24].
According to phenotypic method, in the current study, the
prevalence of ESBLs producing isolates was low (3%) but
according to genotypic method, more than 97% of isolates
carried at least one gene encoding ESBLs. This may be related
to the phenotypic ESBLs detection methods. The current ESBLs
detection methods for P. aeruginosa are unreliable and because
of mutational derepression of the chromosomally mediated
AmpC enzyme, up-regulation of efflux system and decreased
outer membrane permeability, the reported numbers of ESBLs
producers are usually low [25–27].f extended spectrum beta-lactamases, metallo-beta-lactamases and
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Table 2 – Distribution of the ESBL and MBL genes, antimicrobial MIC and RAPD types among carbapenem-resistant
Pseudomonas aeruginosa isolates.
Resistance genes Number of isolates Range of MIC (mg/ml) RAPD type
IMIa IMI + COL MEM MEM + COL CAZ CAZ + COL
OXA-10 14 16–64 4–64 4–64 2–64 2–2048 2–4096 A
OXA-10 1 16 4 16 16 8 8 NTb
IMP 1 32 8 32 32 16 16 A
TEM 1 16 8 32 32 4096 1024 NT
TEM + VIM 1 16 4 32 32 2 32 A
OXA-10 + IMP 2 32 8 16 16 4–8 2–4 A
OXA-10 + TEM 14 16–64 4–32 8–128 4–128 4–4096 4–4096 A
OXA-10 + TEM 1 32 8 32 16 4 4 B
OXA-10 + TEM 1 64 32 32 32 4096 1024 C
OXA-10 + TEM 1 32 16 64 64 512 512 G
OXA-10 + TEM 2 32 2–16 32 16–32 8–2048 8–2048 NT
OXA-10 + VIM 15 32–256 4–256 4–128 2–128 8–4096 8–4096 A
OXA-10 + VIM 1 64 16 8 4 2048 512 B
OXA-10 + VIM 2 16–64 8–32 16–64 16–64 1024 512 NT
OXA-10 + TEM + PER 2 64 32 64–128 64–128 4096 4096 A
OXA-10 + TEM + PER 1 64 32 32 32 2048 2048 I
OXA-10 + TEM + PER 1 16 16 64 64 4096 4096 K
OXA-10 + TEM + PER 1 64 32 32 32 2048 2048 L
OXA-10 + TEM + PER 1 64 16 16 16 32 32 M
OXA-10 + TEM + VIM 26 32–512 4–256 4–256 2–256 2–4096 2–4096 A
OXA-10 + TEM + VIM 1 32 8 32 32 16 16 D
OXA-10 + TEM + VIM 1 128 32 64 64 4096 4096 F
OXA-10 + TEM + VIM 1 32 8 16 16 16 16 H
OXA-10 + TEM + VIM 2 64–128 16–64 4–64 4–64 2048–4096 1024–4096 NT
OXA-10 + PER + VIM 3 64 16–32 16–32 16 32–2048 32–1024 A
OXA-10 +TEM + PER + VIM 2 64 16 16–32 16–32 2048 1024–2048 A
OXA-10 + TEM + PER + AIM 1 32 4 4 4 2048 2048 E
a IMI: imipenem; COL: cloxacillin; MEM: meropenem; CAZ: ceftazidime.
b NT: not typeable.
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JBUR-4303; No. of Pages 6To date, different families of class A ESBLs (TEM, SHV, CTX-
M, PER, VEB, GES and IBC families) were reported in P.
aeruginosa isolates [4]. In the present study, the most prevalent
ESBLs genes were blaOXA-10, blaTEM and blaPER accounted for
97%, 61% and 13% of isolates respectively. OXA-10 is
responsible for high level of resistance to carboxypenicillines,
uriedopenicillines and cephalosporins [23]. OXA type ESBLs
were the predominant ESBLs in P. aeruginosa reported by a
number of studies from Iran [4,15]. However, the rates of genes
encoding ESBLs among P. aeruginosa vary greatly among
different locations in one or more countries [23,24].
Carbapenemase production is increasing worldwide as a
major mechanism of carbapenem resistance among P.
aeruginosa isolates [26,29], and this mechanism is seen
commonly in Iran [10,11]. In the present study, 65% of isolates
were found to produce carbapenemase. The VIM enzymes
were the most common MBLs found in carbapenem-resistant
bacteria, including carbapenem-resistant P. aeruginosa [24,26].
The blaVIM or blaIMP gene carrying P. aeruginosa were previously
recognized in Tehran and other regions of Iran [10,11,28] like
those in the present study, these genes were the most
prevalent genes encoding carbapenemase enzymes, however
to our knowledge; this is the first report of detection of blaAIM
MBLs gene from P. aeruginosa isolates in Iran. The addition of a
new resistance determinant makes a serious problem on the
therapeutic choices existing for treatment of infections caused
by P. aeruginosa.Please cite this article in press as: Neyestanaki DK, et al. Determination o
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10.1016/j.burns.2014.02.010In the absence of MBLs enzymes carbapenem resistance is
frequently multifactorial including increased production of
AmpC chromosome-encoded cephalosporinase [8]. AmpC
beta-lactamases can confer resistance to aminopenicillins,
cephalosporins, oxyimino-cephalosporins, cephamycins, car-
bapenems and monobactams. In the present study, 52% of
isolates showed AmpC overproduction. Therefore, the pro-
duction of MBLs enzyme and AmpC beta-lactamases are the
major emerging mechanism of resistance carbapenem among
P. aeruginosa isolates in Tehran, Iran. Compatible with other
studies from Iran our isolates were negative for the blaPSE,
blaCTX-M, blaOXA-48, blaKPC, blaGES, blaGIM, blaSPM, blaNDM, and
blaSIM genes [10,11]. Concerning antimicrobial susceptibility,
all the carbapenem-resistant P. aeruginosa investigated in this
study retained susceptibility to polymyxin B.
The typing methods were used as a means of characteri-
zation and discrimination of the isolates based on either their
genotypic or phenotypic features. Successful application of
the RAPD typing method for the genotypic characterization of
P. aeruginosa isolates was documented in several studies [30–
32]. According to the results of the current study, 80% of the
strains belonged to the one RAPD type A. This may suggest the
existence of endemic clones that re-circulated among the
patients.
In conclusion, this is the first report of Adelaide IMipen-
mase (AIM) MBL producing P. aeruginosa from Iran and also of
the high prevalence of AmpC overproduction isolates. Thef extended spectrum beta-lactamases, metallo-beta-lactamases and
ginosa isolated from burn patients. Burns (2014), http://dx.doi.org/
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JBUR-4303; No. of Pages 6present study shows that P. aeruginosa isolates producing OXA-
10, TEM, VIM, PER and IMP beta-lactamases are common and
the population structure of these isolates is highly similar.
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